ArticleJournal for immunotherapy of cancer2018

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.

Mariaelena Capone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.